High Flow Nasal Cannula is Appropriate Alternative for Stabilization of Very Premature Infants: a Prospective Observational Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 65
- 试验地点
- 2
- 主要终点
- HFNC slabilization
研究概览
简要总结
A prospective observational study evaluates the safety and efficacy of using High-Flow Nasal Cannula to stabilize very preterm infants immediately after birth. Following placental transfusion, high flow nasal cannula at 8 l/min is administered along with intermittent tactile stimulation. Criteria for switching to other interventions like continuous positive airway pressure or positive pressure ventilation are set for cases of persistent bradycardia or low SpO2.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 0 Minutes 至 2 Minutes(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Preterm infants born between 28+0 and 31+6 gestational weeks were enrolled in the study after obtaining parental informed consent.
排除标准
- •Infants with congenital malformations, previable rupture of membranes, and acute intrauterine hypoxia.
结局指标
主要结局
HFNC slabilization
时间窗: 10 minutes after delivery
Number of infants who were stabilized after birth on high flow nasal cannula exclusively without any other use of artificial external pressures.
次要结局
未报告次要终点
研究者
Jonáš Klára
Principal Investigator
Charles University, Czech Republic
